Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Appropriate premedication risk reduction during adrenal ablation

Deepak Sudheendra, Bradford J Wood

    Journal of Vascular and Interventional Radiology : JVIR
    |August 23, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.

    The Lancet. Oncology·2026
    Same author

    International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.

    The Lancet. Oncology·2026
    Same author

    Development and Validation of a Multimodal AI-Based Model for Predicting Post-Prostatectomy Treatment Outcomes from Baseline Biparametric Prostate MRI.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Evaluating Clinically Significant Prostate Cancer with Pathology-Registered Radiomics: A Multi-Reader Assessment Using Lesion Diameter-based Simplified Segmentations on MRI.

    Academic radiology·2026
    Same author

    Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver.

    PloS one·2026
    Same author

    Tumor-Targeted IL-12 (PDS01ADC) with Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Non-randomized Phase II Trial.

    JCO oncology advances·2026